Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Torkelson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medical and Pediatric Oncology|May 1, 1995
Long-term follow-up of stage III testicular carcinoma treated with mithramycin (plicamycin)B J Kennedy, J L Torkelson
Cancer Investigation|May 20, 1998
Familial hearing loss and cisplatin therapyB J Kennedy, J L Torkelson
Cancer|May 18, 1999
Uracil mustard revisitedB J Kennedy, J L Torkelson, E Torlakovic
Cancer|March 1, 1994
Adjuvant chemotherapy for stage II nonseminomatous germ cell cancer of the testisB J Kennedy, J L Torkelson, E E Fraley
American Journal of Clinical Oncology|December 1, 1996
Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinomaB J Kennedy, J L Torkelson, E E Fraley
Cancer|December 15, 1985
Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycinN J Vogelzang, J L Torkelson, B J Kennedy
Cancer|September 15, 1990
Poor prognosis of mediastinal germ cell cancers containing sarcomatous componentsJ L Gonzalez-Vela, P D Savage, J C Manivel, et al.
American Journal of Clinical Oncology|August 1, 1992
Extragonadal abdominal germ cell cancersJ L Gonzalez-Vela, M A Villalona-Calero, J L Torkelson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical and Pediatric Oncology|May 1, 1995
Long-term follow-up of stage III testicular carcinoma treated with mithramycin (plicamycin)B J Kennedy, J L Torkelson
Cancer Investigation|May 20, 1998
Familial hearing loss and cisplatin therapyB J Kennedy, J L Torkelson
Cancer|May 18, 1999
Uracil mustard revisitedB J Kennedy, J L Torkelson, E Torlakovic
Cancer|March 1, 1994
Adjuvant chemotherapy for stage II nonseminomatous germ cell cancer of the testisB J Kennedy, J L Torkelson, E E Fraley
American Journal of Clinical Oncology|December 1, 1996
Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinomaB J Kennedy, J L Torkelson, E E Fraley
Cancer|December 15, 1985
Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycinN J Vogelzang, J L Torkelson, B J Kennedy
Cancer|September 15, 1990
Poor prognosis of mediastinal germ cell cancers containing sarcomatous componentsJ L Gonzalez-Vela, P D Savage, J C Manivel, et al.
American Journal of Clinical Oncology|August 1, 1992
Extragonadal abdominal germ cell cancersJ L Gonzalez-Vela, M A Villalona-Calero, J L Torkelson, et al.
Pageof 1